Miguel Mutti is a senior executive with 25 years’ experience in general management, business development and M&A, integration and restructuring in the healthcare and pharma industry. After starting his career in investment banking at Salomon Smith Barney/ Citigroup in the M&A and ECM, Miguel Mutti joined the industry where he spent the last 15 years …
Since 2010, Paolo is CEO of GDS Communication, a communication and marketing agency in the Healthcare sector, which joined ” The European House Ambrosetti ” in April 2023. He is Principal Expert and Member of the Development Committee of “The European House Ambrosetti “. Since 2022 he is President of Confindustria Giovani di Como and …
Paola has been a manager and an entrepreneur, and now she is also a business angel and keep going as a mom of a 9 years old daughter. Paola has spent 11 years as a talented manager with growing business responsibilities in P&G, both pharma and mass market, then Astrazeneca, UCB and BMS. In 2010 …
Davide is an Angel Investor, member of several italian BAN, and deal flower for other companies. He works with startups also as a Mentor, directly and for different incubators/accelerators such as Murate Idea Park (Firenze), Impact Hub (Milano) and Social Innovation Teams (Torino). He is Business Designer and Business Coach accredited with ICF, and …
LUCA SPACCAPELO, MD, PHARMACOLOGIST, MBA Graduate with honors in Medicine and Surgery, Luca started his academic career as clinical pharmacologist involved in clinical and research activities at the division of toxicology and clinical pharmacology of the University of Modena and Reggio Emilia. From 2009 and 2012, Luca has been author or co-author of 21 scientific …
Law graduate, with international experience of research in the field of Business Law at Cambridge University and UCL, Nicolò has been a student at Collegio Borromeo of Pavia and a great Medtech and Biotech enthusiast. He acquired experience in this field during a period spent in San Francisco as a selected student from the Mind …
FEDERICA Girolami Federica is Business Development, Scientific Liaison and Drug Safety Director at Rottapharm Biotech, where she is responsible for negotiations, alliances, and licensing activities. In her role as Scientific Liaison, she cultivates relationships with academic researchers and key opinion leaders. Given her long-standing experience in Pharmacovigilance, she is also responsible for all Drug Safety …
Max is Professor of Applied Biology at University of Catania, Italy and director of the laboratory of Systems and Synthetic Biology at the Department of Drug Sciences. He is Medical Doctor with a PhD in Embryology. He was a researcher at CNR (I), MRC (UK), San Raffaele (I), and KCL (UK); he received a Mini-MBA™: …
Roberto is an investor in the biotech space, with +15 years of investing experience spanning from early stage to private equity deals across multiple geographies. He serves on the Board of multiple life-science companies throughout Europe and the US, including Vasopharm GmbH (Germany, traumatic brain injury), GNS Healthcare (Cambridge, digital health), Medinet (UK, outsourcing services). …
Pierfrancesco is CEO of Ricerchimica S.r.l. a consulting company focused on M&A and transaction services in Lifescience. He has over 25-year experience in Pharmaceuticals at European level with particular expertise in the Italian and Spanish market, where Ricerchimica was present, in Barcelona, with their own offices for over 5 years. Pierfrancesco has a wide experience …
